123 related articles for article (PubMed ID: 12515704)
21. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.
Bolan PJ; Meisamy S; Baker EH; Lin J; Emory T; Nelson M; Everson LI; Yee D; Garwood M
Magn Reson Med; 2003 Dec; 50(6):1134-43. PubMed ID: 14648561
[TBL] [Abstract][Full Text] [Related]
22. Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo.
Lemaire LP; McSheehy PM; Griffiths JR
Cancer Chemother Pharmacol; 1998; 42(3):201-9. PubMed ID: 9685055
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of motion compensation strategies and repeatability for abdominal (1)H MR spectroscopy measurements in volunteer studies and clinical trials.
Germuska M; Tunariu N; Leach MO; Xu J; Payne GS
NMR Biomed; 2012 Jun; 25(6):859-65. PubMed ID: 22190219
[TBL] [Abstract][Full Text] [Related]
25. In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.
Walker P; Provent P; Tizon X; Créhange G; Duchamp O; Brunotte F; Genne P
Acta Radiol; 2013 Feb; 54(1):121-6. PubMed ID: 23081956
[TBL] [Abstract][Full Text] [Related]
26. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
27. [Feasibility of proton magnetic resonance spectroscopy of the myocardium in vivo].
Wu J; Yang L; Yang CH; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2295-7. PubMed ID: 20965829
[TBL] [Abstract][Full Text] [Related]
28. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
29. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of predictive value of 1H MR spectroscopy for response of neoadjuvant chemotherapy in musculoskeletal tumors.
Cirkovic P; Mihailovic J; Paripovic L; Ilic V; Ristic D; Djurisic I; Djordjevic A; Maksimovic R
J BUON; 2018; 23(6):1867-1873. PubMed ID: 30610815
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
32. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
33. Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model.
Rommel D; Abarca-Quinones J; Bol A; Peeters F; Lhommel R; Lonneux M; Labar D; Gregoire V; Duprez T
Nucl Med Biol; 2010 Jul; 37(5):645-53. PubMed ID: 20610169
[TBL] [Abstract][Full Text] [Related]
34. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
35. Proof-of-the-Concept Study on Mathematically Optimized Magnetic Resonance Spectroscopy for Breast Cancer Diagnostics.
Belkić D; Belkić K
Technol Cancer Res Treat; 2015 Jun; 14(3):277-97. PubMed ID: 25246518
[TBL] [Abstract][Full Text] [Related]
36. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study.
Raininko R; Mattsson P
Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295
[TBL] [Abstract][Full Text] [Related]
37. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.
Bolan PJ; Kim E; Herman BA; Newstead GM; Rosen MA; Schnall MD; Pisano ED; Weatherall PT; Morris EA; Lehman CD; Garwood M; Nelson MT; Yee D; Polin SM; Esserman LJ; Gatsonis CA; Metzger GJ; Newitt DC; Partridge SC; Hylton NM;
J Magn Reson Imaging; 2017 Jul; 46(1):290-302. PubMed ID: 27981651
[TBL] [Abstract][Full Text] [Related]
38. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
39. In vivo 1H MR spectroscopy of thyroid carcinoma.
King AD; Yeung DK; Ahuja AT; Tse GM; Chan AB; Lam SS; van Hasselt AC
Eur J Radiol; 2005 Apr; 54(1):112-7. PubMed ID: 15797300
[TBL] [Abstract][Full Text] [Related]
40. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
